BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Söderholm S, Fu Y, Gaelings L, Belanov S, Yetukuri L, Berlinkov M, Cheltsov AV, Anders S, Aittokallio T, Nyman TA, Matikainen S, Kainov DE. Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction. Viruses 2016;8:E269. [PMID: 27690086 DOI: 10.3390/v8100269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Aishwarya S, Gunasekaran K, Sagaya Jansi R, Sangeetha G. From genomes to molecular dynamics - A bottom up approach in extrication of SARS CoV-2 main protease inhibitors. Comput Toxicol 2021;18:100156. [PMID: 33532671 DOI: 10.1016/j.comtox.2021.100156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Beale DJ, Oh DY, Karpe AV, Tai C, Dunn MS, Tilmanis D, Palombo EA, Hurt AC. Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment. Metabolomics 2019;15:33. [PMID: 30830484 DOI: 10.1007/s11306-019-1499-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
3 Ianevski A, Yao R, Zusinaite E, Lysvand H, Oksenych V, Tenson T, Bjørås M, Kainov D. Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot Study. Viruses 2021;13:1537. [PMID: 34452402 DOI: 10.3390/v13081537] [Reference Citation Analysis]
4 Maldonado-Carmona N, Vázquez-Hernández M, Patiño Chávez OJ, Rodríguez-Luna SD, Jiménez Rodríguez O, Sanchez S, Ceapă CD. Impact of ∼omics in the detection and validation of potential anti-infective drugs. Curr Opin Pharmacol 2019;48:1-7. [PMID: 30921690 DOI: 10.1016/j.coph.2019.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Klemm C, Boergeling Y, Ludwig S, Ehrhardt C. Immunomodulatory Nonstructural Proteins of Influenza A Viruses. Trends Microbiol 2018;26:624-36. [PMID: 29373257 DOI: 10.1016/j.tim.2017.12.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
6 Adeola HA, Van Wyk JC, Arowolo A, Ngwanya RM, Mkentane K, Khumalo NP. Emerging Diagnostic and Therapeutic Potentials of Human Hair Proteomics. Proteomics Clin Appl 2018;12. [PMID: 28960873 DOI: 10.1002/prca.201700048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
7 Bösl K, Ianevski A, Than TT, Andersen PI, Kuivanen S, Teppor M, Zusinaite E, Dumpis U, Vitkauskiene A, Cox RJ, Kallio-Kokko H, Bergqvist A, Tenson T, Merits A, Oksenych V, Bjørås M, Anthonsen MW, Shum D, Kaarbø M, Vapalahti O, Windisch MP, Superti-Furga G, Snijder B, Kainov D, Kandasamy RK. Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis. Front Immunol 2019;10:2186. [PMID: 31636628 DOI: 10.3389/fimmu.2019.02186] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
8 Shim JM, Kim J, Tenson T, Min JY, Kainov DE. Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis. Viruses 2017;9:E223. [PMID: 28805681 DOI: 10.3390/v9080223] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
9 Boergeling Y, Brunotte L, Ludwig S. Dynamic phospho-modification of viral proteins as a crucial regulatory layer of influenza A virus replication and innate immune responses. Biol Chem 2021. [PMID: 34062629 DOI: 10.1515/hsz-2021-0241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni JC, Buettner F, Huber W, Stegle O. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol 2018;14:e8124. [PMID: 29925568 DOI: 10.15252/msb.20178124] [Cited by in Crossref: 234] [Cited by in F6Publishing: 202] [Article Influence: 58.5] [Reference Citation Analysis]
11 Ianevski A, Andersen PI, Merits A, Bjørås M, Kainov D. Expanding the activity spectrum of antiviral agents. Drug Discov Today 2019;24:1224-8. [PMID: 30980905 DOI: 10.1016/j.drudis.2019.04.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
12 Sadewasser A, Paki K, Eichelbaum K, Bogdanow B, Saenger S, Budt M, Lesch M, Hinz KP, Herrmann A, Meyer TF, Karlas A, Selbach M, Wolff T. Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells. Mol Cell Proteomics 2017;16:728-42. [PMID: 28289176 DOI: 10.1074/mcp.M116.065904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
13 Kuivanen S, Bespalov MM, Nandania J, Ianevski A, Velagapudi V, De Brabander JK, Kainov DE, Vapalahti O. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. Antiviral Res 2017;139:117-28. [PMID: 28049006 DOI: 10.1016/j.antiviral.2016.12.022] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 10.5] [Reference Citation Analysis]
14 Gaelings L, Söderholm S, Bugai A, Fu Y, Nandania J, Schepens B, Lorey MB, Tynell J, Vande Ginste L, Le Goffic R, Miller MS, Kuisma M, Marjomäki V, De Brabander J, Matikainen S, Nyman TA, Bamford DH, Saelens X, Julkunen I, Paavilainen H, Hukkanen V, Velagapudi V, Kainov DE. Regulation of kynurenine biosynthesis during influenza virus infection. FEBS J 2017;284:222-36. [PMID: 27860276 DOI: 10.1111/febs.13966] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]